David Fallace
Managing Partner at Cure Ventures
About
Co-founder of Cure Ventures with over 20 years of investment experience across venture capital and alternative asset funds. Held senior roles at major firms including Polaris Partners, TIFF Investment Management, and the Alaska Permanent Fund Corporation, serving on boards of multiple successful biotech companies including Juno Therapeutics and Denali Therapeutics.
Investments
Board seats
RYNE Biotechnology Inc.Tasca Therapeutics Corp
As listed on the firm's website.
Colleagues at Cure Ventures
Albert J. Robichaud
Partner at Cure Ventures
Annie Mitsak
Partner at Cure Ventures
Courtney Turner
Director of Finance at Cure Ventures
Dr. Michael Aberman
Investor at Cure Ventures
Dr. Milenko Cicmil
Investor at Cure Ventures
Drew King
CFO and Partner at Cure Ventures
Jeffrey M. Jonas
Partner at Cure Ventures
Jeno Gyuris
Partner at Cure Ventures